Importance of Preventative Vaccines for Medicare Advantage Plan Holders
Preventative vaccines play a crucial role in safeguarding the health and well-being of individuals, particularly for Medicare Advantage plan holders. Seniors are more vulnerable to picking up various diseases and their complications.
Vaccines offer a proactive approach to disease prevention, significantly reducing the risk of infections and their associated health burdens.
Influenza (flu) vaccine is a critical preventative measure for seniors. Each year, the flu virus evolves, making it essential for individuals, especially older adults, to receive an annual flu shot. The flu can lead to severe complications in seniors, including pneumonia and hospitalization.
The influenza vaccine stimulates the body’s immune response, providing protection against the circulating strains of the flu virus. By getting vaccinated, Medicare Advantage plan holders can significantly reduce their risk of contracting the flu, lessen the severity of symptoms if they do become infected, and avoid potential complications.
Pneumococcal diseases, including pneumonia, bacteremia, and meningitis, are common and potentially life-threatening infections for seniors. Medicare Advantage plan holders are eligible for two types of pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
PCV13 is recommended for all adults aged 65 and older, providing protection against 13 strains of pneumococcal bacteria. PPSV23, on the other hand, is typically administered one year after PCV13 and provides additional coverage against 23 strains.
Shingles, also known as herpes zoster, is an agonizing viral infection resulting from the reawakening of the varicella-zoster virus (VZV), the same virus responsible for causing chickenpox. Seniors are particularly susceptible to shingles, and its complications can include severe pain, nerve damage (postherpetic neuralgia), and skin infections.
The shingles vaccine, known as Zoster Vaccine Live (ZVL) or Shingrix, is highly recommended for Medicare Advantage plan holders. It is a two-dose vaccine that offers long-lasting protection against shingles.
The vaccine stimulates the immune system, reducing the risk of developing shingles and its associated complications. Even if a person has had shingles in the past, the vaccine can help prevent a recurrence and alleviate the intensity of symptoms.
Tetanus, Diphtheria, Pertussis Vaccine
Tetanus, diphtheria, and pertussis (Tdap) vaccines are essential for Medicare Advantage plan holders to protect against these potentially serious and sometimes deadly diseases. Tetanus, or lockjaw, is caused by bacteria entering the body through wounds or cuts. Diphtheria is a respiratory infection that can lead to severe complications.
Pertussis, or whooping cough, is a highly contagious respiratory infection that can be especially dangerous for older adults.
The Tdap vaccine boosts immunity against all three diseases, protecting and preventing their transmission.
Other Recommended Vaccines
What Our Clients Are Saying
“Wonderful organization. Very Honest, caring, and professional. I would definitely recommend them to family and friends.”
“We have had a hard time finding insurance, as many others might have been doing recently. Finding SHA now was literal lifesaver..”
“There just aren't enough stars on this page for Danny - he went above & beyond to help us. He returned every phone call & answered every question we had.”